Loading...
Loading...
TOIIW| Name | Value |
|---|---|
| Revenues | 99.9M |
| Cost of Revenue | 85.5M |
| Gross Profit | 14.4M |
| Operating Expense | 28.2M |
| Operating I/L | -13.9M |
| Other Income/Expense | -2.3M |
| Interest Income | 0.0M |
| Pretax | -16.1M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -16.1M |
The Oncology Institute, Inc. is a leading provider of medical oncology services in the United States. The company generates revenue through a range of services including physician services, in-house infusion and dispensary, outpatient stem cell transplants and transfusions programs, and patient support. Additionally, it offers and manages clinical trial services, palliative care programs, and stem cell transplants for cancer patients, contributing to its overall business model.
